Eltrombopag olamine
-
Eltrombopag olamine
structure -
-
CAS No:
496775-62-3
-
Formula:
C25H22N4O4.2C2H7NO
-
Chemical Name:
Eltrombopag olamine
-
Synonyms:
[1,1′-Biphenyl]-3-carboxylic acid,3′-[(2Z)-2-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazinyl]-2′-hydroxy-,compd. with 2-aminoethanol (1:2);[1,1′-Biphenyl]-3-carboxylic acid,3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-,compd. with 2-aminoethanol (1:2);SB 497115GR;Eltrombopag olamine;Promacta;Eltrombopag diethanolamine salt;Revolade
- Categories:
-
CAS No:
Description
Eltrombopag is a thrombopoietin-receptor agonist used to treat low blood platelet counts with chronic immune thrombocytopenia.
Eltrombopag Olamine is the orally active ethanolamine salt of eltrombopag, a small-molecule, nonpeptide thrombopoietin receptor agonist with megakaryopoiesis-stimulating activity. Eltrombopag binds to and stimulates the transmembrane domain of the platelet thrombopoietin receptor (TPO-R or CD110), a member of the hematopoietin receptor superfamily. Activation of TPO-R leads to the proliferation and differentiation of cells in the megakaryocytic lineage and an increase in platelet production.
Safety Information
|Danger|H302 (16.67%): Harmful if swallowed [Warning Acute toxicity, oral]|P260, P264, P270, P273, P280, P301+P312, P305+P351+P338, P310, P314, P330, P337+P313, P391, and P501|Aggregated GHS information provided by 6 companies from 6 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Drug Information
Revolade is indicated for chronic immune (idiopathic) thrombocytopenic purpura (ITP) patients aged 1 year and above who are refractory to other treatments (e.g. corticosteroids, immunoglobulins).Revolade is indicated in adult patients with chronic hepatitis C virus (HCV) infection for the treatment of thrombocytopenia, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy.Revolade is indicated in adult patients with acquired severe aplastic anaemia (SAA) who were either refractory to prior immunosuppressive therapy or heavily pretreated and are unsuitable for haematopoietic stem cell transplantation.|Drug: Eltrombopagolamine
eltrombopag
Eltrombopag olamine Use and Manufacturing
Treatment of chemotherapy-induced thrombocytopenia and treatment of immune thrombocytopenic purpura.
Human drugs -> Revolade -> EMA Drug Category|Other systemic hemostatics, Antihemorrhagics -> Human pharmacotherapeutic group|Human drugs -> Rare disease (orphan)|Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients
Computed Properties
Molecular Weight:564.6
Hydrogen Bond Donor Count:7
Hydrogen Bond Acceptor Count:11
Rotatable Bond Count:7
Exact Mass:564.26963289
Monoisotopic Mass:564.26963289
Topological Polar Surface Area:207
Heavy Atom Count:41
Complexity:822
Covalently-Bonded Unit Count:3
Compound Is Canonicalized:Yes
Drug Function and Efficacy
This product is an orally bioavailable, small molecule thrombopoietin (TPO) receptor agonist that interacts with the transmembrane domain of the human TPO receptor, initiates a signaling cascade, and induces proliferation and differentiation of bone marrow progenitor cells. Due to the unique specificity of the TPO receptor, eltrombopag does not stimulate platelet production in rats, mice, or dogs.
Registered Holders
-
OPTIMUS DRUGS PRIVATE LTD
Active
United States
-
BIOPHORE INDIA PHARMACEUTICALS PVT LTD
Active
United States
-
SHILPA PHARMA LIFESCIENCES LTD
Active
United States
Recommended Suppliers of Eltrombopag olamine
-
CN
3 YRS
Business licensedTrader Supplier of Estradiol,Progesterone,GS441524,4-Butylresorcinol,DeoxyArbutin,Coenzyme Q10,Piracetam,Pregabalin,Ketoprofen,omeprazole,Fullerene C60,Melatonin,Nicotinamide riboside chloride,lactoferrin,Tylosin tartrate,Gentamycin Sulfate,Levamisole HCl,Praziquantel,Ivermectin,GA3,Pepsin,MT2,5 amino 1MQ,selank,semaxInquiryCAS No.: 496775-62-3Grade: Pharmaceutical GradeContent: 99% -
CN
2 YRS
Business licensedTrader Supplier of Pharmaceutical intermediates -
CN
2 YRS
Business licensedTrader Supplier of Peptide,API,HCG,Amino Acids,Plant Extract,VitaminInquiryCAS No.: 496775-62-3Grade: Pharmaceutical GradeContent: 99% -
CN
3 YRS
Business licensed Certified factoryManufactory Supplier of Dyes,Textile agent,Medical intermediate,API,Pigments,Basic Chemicals -
CN
3 YRS
Business licensedTrader Supplier of api,Intermediates,Organic Chemistry,Inorganic Chemistry,Daily Chemicals,Cosmetic Raw Materals,CATALYST AND AUXILIARY,FLAVORS AND FRAGRANCES,Chemical Pesticides,ADDITIVEInquiryCAS No.: 496775-62-3Grade: Analytical ReagentContent: 99%
Learn More Other Chemicals
-
Eltrombopag
496775-61-2
-
Ciclopirox olamine
41621-49-2
-
Clopyralid olamine
57754-85-5
-
Piroctone olamine Formula
68890-66-4
-
HEXANES Formula
73513-42-5
-
4-Bromobenzamide Formula
698-67-9
-
Najera Catalyst II Structure
419581-64-9
-
Diaminomaleonitrile Structure
1187-42-4
-
What is N-Methyl-4-nitro-N-[2-(4-nitrophenoxy)ethyl]benzeneethanamine
115287-37-1
-
What is (S)-3-Hydroxypyrrolidine
100243-39-8